AMN Insider Filing: 483 RSUs Vest, 118 Shares Withheld for Taxes

Rhea-AI Filing Summary

Whitney M. Laughlin, Chief Legal Officer of AMN Healthcare Services, reported on Form 4 that 483 restricted stock units (RSUs) vested on September 15, 2025, converting into 483 shares of AMN common stock. Of those shares, 118 were sold or withheld at $18.25 per share to satisfy tax withholding, leaving the reporting person with 16,732 shares beneficially owned after the transactions. The RSUs were originally granted under the AMN Healthcare 2017 Equity Plan on September 15, 2023 and vest in three annual tranches; the units have no expiration date. The report is a routine insider equity vesting and tax-withholding transaction rather than a discretionary open-market purchase or sale.

Positive

• Retention of shares following vesting (16,732 shares remained beneficially owned), indicating continued insider ownership alignment with shareholders
• Vesting occurred as scheduled under the AMN Healthcare 2017 Equity Plan, reflecting predictable compensation governance

Negative

• Partial disposition for tax withholding (118 shares at $18.25), which reduces the net increase in insider holdings from the vesting event

Insights

Corporate Governance Expert

TL;DR: Routine executive compensation vesting and tax withholding; no new governance signals.

The filing documents scheduled vesting of RSUs and customary withholding to meet tax obligations, which is standard practice for equity compensation. The transaction does not indicate any change in board composition, executive role, or control. The remaining beneficial ownership level of 16,732 shares should be viewed as part of normal compensation retention rather than a deliberate liquidity event. No material governance concerns are evident from this single Form 4.

Securities Analyst

TL;DR: Small, routine vesting and withholding; unlikely to move market or alter investor thesis.

The report shows 483 RSUs vested with 118 shares withheld at a price of $18.25 to cover taxes, which implies a standard net-share settlement process. The scale of the transaction is immaterial relative to typical public float and does not represent an opportunistic sale. Investors monitoring insider activity can note continued retention of shares following compensation vesting, but this single entry provides limited actionable information about company performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Laughlin Whitney M

(Last) (First) (Middle)

2999 OLYMPUS BOULEVARD, SUITE 500

(Street)

DALLAS TX 75019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		M(1)		483	A	$0	16,850	D
Common Stock	09/15/2025		F(2)		118	D	$18.25	16,732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	09/15/2025		M			483	(4)	(5)	Common Stock	483	$0	498	D

Explanation of Responses:

1. Common stock acquired on the vesting of Restricted Stock Units.

2. Number of shares withheld for tax purposes.

3. The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

4. The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date.

5. Restricted Stock Units do not have an expiration date.

Remarks:

	/s/ Whitney M. Laughlin	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AMN (AMN) insider Whitney M. Laughlin report on Form 4?

The report discloses that 483 RSUs vested on September 15, 2025, 118 shares were withheld at $18.25 for taxes, leaving 16,732 shares beneficially owned.

Why were 118 shares disposed of in the Form 4 transaction?

The filing states 118 shares were withheld for tax purposes to satisfy tax withholding obligations upon RSU vesting.

When were the RSUs originally granted and under which plan?

The RSUs were granted on September 15, 2023 under the AMN Healthcare 2017 Equity Plan and vest in three annual tranches.

Does the Form 4 indicate a sale to raise cash or a market disposition?

No; the report classifies the 118-share disposition as tax withholding rather than an open-market sale, indicating routine settlement.

How many total shares did Whitney M. Laughlin own after the reported transactions?

Following the transactions on September 15, 2025, the reporting person beneficially owned 16,732 shares.